Traders sold shares of DaVita HealthCare Partners Inc. (NYSE:DVA) on strength during trading hours on Friday. $20.29 million flowed into the stock on the tick-up and $191.26 million flowed out of the stock on the tick-down, for a money net flow of $170.97 million out of the stock. Of all stocks tracked, DaVita HealthCare Partners had the 0th highest net out-flow for the day. DaVita HealthCare Partners traded up $0.33 for the day and closed at $77.91

DVA has been the subject of several research reports. Jefferies Group reissued a “buy” rating on shares of DaVita HealthCare Partners in a research report on Monday, April 4th. Susquehanna increased their price objective on DaVita HealthCare Partners from $70.00 to $78.00 and gave the company a “neutral” rating in a research report on Wednesday, April 6th. TheStreet raised DaVita HealthCare Partners from a “hold” rating to a “buy” rating in a research report on Wednesday, May 4th. Robert W. Baird reissued a “buy” rating on shares of DaVita HealthCare Partners in a research report on Sunday, May 8th. Finally, Wells Fargo & Co. reissued a “buy” rating on shares of DaVita HealthCare Partners in a research report on Saturday, June 4th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company. DaVita HealthCare Partners currently has an average rating of “Hold” and an average target price of $78.88.

The stock has a 50-day moving average of $76.70 and a 200-day moving average of $72.31. The company has a market capitalization of $16.09 billion and a PE ratio of 34.95.

DaVita HealthCare Partners (NYSE:DVA) last posted its earnings results on Wednesday, May 4th. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.06. The business had revenue of $3.58 billion for the quarter, compared to analyst estimates of $3.51 billion. During the same period in the previous year, the firm posted $0.86 earnings per share. The firm’s revenue was up 8.9% compared to the same quarter last year. Equities research analysts anticipate that DaVita HealthCare Partners Inc. will post $3.95 EPS for the current fiscal year.

In related news, insider Jeanine Marie Jiganti sold 1,291 shares of the business’s stock in a transaction that occurred on Monday, July 11th. The stock was sold at an average price of $78.51, for a total transaction of $101,356.41. Following the transaction, the insider now directly owns 5,716 shares of the company’s stock, valued at approximately $448,763.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Dennis Kogod sold 40,048 shares of the business’s stock in a transaction that occurred on Tuesday, May 10th. The stock was sold at an average price of $76.25, for a total value of $3,053,660.00. Following the transaction, the chief executive officer now directly owns 92,716 shares in the company, valued at $7,069,595. The disclosure for this sale can be found here.

A number of hedge funds have recently added to or reduced their stakes in DVA. Vanguard Group Inc. increased its stake in DaVita HealthCare Partners by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 14,380,779 shares of the company’s stock valued at $1,002,484,000 after buying an additional 137,560 shares during the period. Egerton Capital UK LLP increased its stake in DaVita HealthCare Partners by 2.6% in the fourth quarter. Egerton Capital UK LLP now owns 4,556,554 shares of the company’s stock valued at $317,637,000 after buying an additional 114,991 shares during the period. Principal Financial Group Inc. increased its stake in DaVita HealthCare Partners by 14.5% in the fourth quarter. Principal Financial Group Inc. now owns 2,365,751 shares of the company’s stock valued at $164,916,000 after buying an additional 299,194 shares during the period. Morgan Stanley increased its stake in DaVita HealthCare Partners by 15.1% in the fourth quarter. Morgan Stanley now owns 1,635,835 shares of the company’s stock valued at $114,032,000 after buying an additional 214,431 shares during the period. Finally, Nicholas Co. Inc. WI increased its stake in DaVita HealthCare Partners by 16.5% in the fourth quarter. Nicholas Co. Inc. WI now owns 1,458,878 shares of the company’s stock valued at $101,698,000 after buying an additional 206,325 shares during the period.

DaVita HealthCare Partners Inc is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. Its segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. Its Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.